Bristol-Myers Squibb Co.

Amgen to spend $13.4B on Celgene psoriasis drug Otezla

By The Associated Press - Associated Press

Bristol-Myers: 2Q Earnings Snapshot

Associated Press

Bristol-Myers: 1Q Earnings Snapshot

Associated Press

W.Va. settles complaint with drug makers over blood thinner

Associated Press

Bristol-Myers Squibb buying Celgene in $74B deal

Associated Press

High court sides with drugmaker in Plavix lawsuit

Associated Press

Official: Bristol-Myers Squibb to pay to settle allegations

Associated Press

Cancer drug sales boost Bristol-Myers Squibb performance

Associated Press

Bristol-Myers completes diabetes business sale

By NEW YORK - Associated Press

Sales up, 4th-quarter net falls for Bristol-Myers

By LINDA A. JOHNSON - Associated Press

New coupons aim to keep people off generic drugs

By LINDA A. JOHNSON - Associated Press

FDA delays decision on Pfizer, Bristol-Myers drug

By LINDA A. JOHNSON - Associated Press

Bristol ups hepatitis C game in $2.5B acquisition

By ASSOCIATED PRESS - Associated Press

FDA adds new warnings to Bristol cancer drug

By ASSOCIATED PRESS - Associated Press

Bristol-Myers pitches its cancer medicine pipeline

By LINDA A. JOHNSON - Associated Press

Studies find new drugs boost skin cancer survival

By MARILYNN MARCHIONE - Associated Press

FDA clears first melanoma drug to extend survival

By MATTHEW PERRONE - Associated Press

FDA clears first melanoma drug to extend life

By MATTHEW PERRONE - Associated Press

Bristol-Myers Squibb sees 3Q profit dip 2 percent

By LINDA A. JOHNSON - Associated Press

Bristol-Myers: FDA wants factory’s problems fixed

By LINDA A. JOHNSON - Associated Press

Threat Status: High stakes of int’l democracy Daniel Twining joins Guy Taylor

ForAmerica: Trump reshaping foreign policy Watch Tim Constantine and David Bozell

Latest Stories

Amgen to spend $13.4B on Celgene psoriasis drug Otezla

Bristol-Myers: 2Q Earnings Snapshot

Bristol-Myers: 1Q Earnings Snapshot

W.Va. settles complaint with drug makers over blood thinner

Bristol-Myers Squibb buying Celgene in $74B deal

High court sides with drugmaker in Plavix lawsuit

Official: Bristol-Myers Squibb to pay to settle allegations

Cancer drug sales boost Bristol-Myers Squibb performance

Bristol-Myers completes diabetes business sale

Sales up, 4th-quarter net falls for Bristol-Myers

New coupons aim to keep people off generic drugs

FDA delays decision on Pfizer, Bristol-Myers drug

Bristol ups hepatitis C game in $2.5B acquisition

FDA adds new warnings to Bristol cancer drug

Bristol-Myers pitches its cancer medicine pipeline

Studies find new drugs boost skin cancer survival

FDA clears first melanoma drug to extend survival

FDA clears first melanoma drug to extend life

Bristol-Myers Squibb sees 3Q profit dip 2 percent

Bristol-Myers: FDA wants factory’s problems fixed